Successful resuscitation after prolonged periods of cardiac arrest: A new field in cardiac surgery  by Trummer, Georg et al.
PERIOPERATIVE MANAGEMENTSuccessful resuscitation after prolonged periods of cardiac arrest: A
new field in cardiac surgeryGeorg Trummer, MD,a Katharina Foerster, MD,a Gerald D. Buckberg, MD,b Christoph Benk, MD,a
Claudia Heilmann, MD,a Irina Mader, MD,a Friedrich Feuerhake, MD,a Oliver Liakopoulos, MD,b













doi:10.1Objective: Cardiopulmonary resuscitation is associated with high mortality and poor neurological recovery. Car-
diopulmonary resuscitation can cause ischemia–reperfusion injury of the whole body and brain. We assessed the
hypothesis that controlled reperfusion of the whole body with cardiopulmonary bypass would limit reperfusion
injury after 15 minutes of normothermic cardiac arrest with better survival and neurological recovery.
Methods: Eleven pigs were exposed to normothermic ischemia for 15 minutes by inducing ventricular fibrilla-
tion, followed by cardiopulmonary resuscitation (control group, n¼ 4) or 60 minutes of cardiopulmonary bypass
(treatment group, n ¼ 7). Conditions of reperfusion and the reperfusate were controlled with cardiopulmonary
bypass. Animals were observed for up to 7 days, and neurological assessment (Neurological Deficit Score: 0, nor-
mal; 500, brain death), magnetic resonance imaging, and brain histology were performed.
Results: All animals in the control group died after 20 minutes of cardiopulmonary resuscitation (n ¼ 4). All
(n ¼ 7) survived in the treatment group. Clinically apparent neurological recovery occurred within 24 hours;
1 fully conscious pig could not walk. The Neurological Deficit Score was 98  31 in all animals (n ¼ 7) after
24 hours and decreased to 0 after 48 hours in 4 of 5 eligible animals; 1 animal had a Neurological Deficit Score
of 110 after 3 days. Brain histology revealed hypoxic and apoptotic neurons with an inconclusive correlation
regarding neurological recovery.
Conclusion:Clinically apparent neurological recovery after a period of 15 minutes of cardiac arrest occurred with
cardiopulmonary bypass instead of cardiopulmonary resuscitation for reperfusing the whole body. This approach
contrasts with cardiopulmonary resuscitation, in which resuscitation has been reported as successful after only 3
to 5 minutes of cardiac arrest. Cardiopulmonary bypass might be a key to improve survival and neurological
recovery after cardiac arrest. (J Thorac Cardiovasc Surg 2010;139:1325-32)Supplemental material is available online.Sudden cardiac arrest (CA) is the leading worldwide cause
of death.1 Cardiopulmonary resuscitation (CPR) with stan-
dard techniques after CA restores normal cerebral and myo-
cardial function only, provided it occurs within the first 3 to
5 minutes after circulatory standstill.2 Attempts to start CPR
after 10 minutes of CA will result in mortality rates of greater
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The Journal of Thoracic and Car20% to 40% of patients, hospital discharge after initially
successful resuscitation is only approximately 10%.4-6 An-
other 25% to 40% of patients experience an unwitnessed ar-
rest with longer periods of CA; only approximately 1% to
2% of them can be discharged from the hospital.5
Time is the critical factor in determining the outcomes of
patients after CPR as long as normal blood is restored under
normal conditions. However, our studies demonstrated that
tissue can be salvaged for much longer periods of time if
the initial reperfusion after a significant ischemic insult is
controlled (ie, the condition of reperfusion and the composi-
tion of the reperfusate).7-9 The beneficial effects of this treat-
ment regimen are apparent in cardiac and skeletal muscle,
liver, lung, and renal tissue.7,8,10-13 In this report we show
data of clinically apparent neurological, myocardial, and re-
nal recovery after 15 minutes of CA. This might present the
opportunity for a new definition of death, expanding the time
window for successful resuscitation.P
MMATERIAL AND METHODS
Pigs (Deutsche Landrasse) received care in compliance with the rules and
regulations for the use of laboratory animals of the Regierungspra¨sidium
Freiburg, Germany. Protocol 1 (Registration code G-05/64) allowed exper-
iments with a follow-up time of 24 hours, and protocol 2 (Registration code
G-07/04) allowed observation for up to 7 days.diovascular Surgery c Volume 139, Number 5 1325
Abbreviations and Acronyms
ADC ¼ apparent diffusion coefficient
ALT ¼ alanine aminotransferase
AST ¼ aspartate aminotransferase
BW ¼ body weight
CA ¼ cardiac arrest
CPB ¼ cardiopulmonary bypass
CPR ¼ cardiopulmonary resuscitation
CPR–ALS ¼ conventional cardiopulmonary
resuscitation with advanced life
support
MAP ¼ mean arterial pressure
MRI ¼ magnetic resonance imaging
NDS ¼ neurological Deficit Score
VF ¼ ventricular fibrillation
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The control group (n¼ 4) underwent circulatory arrest caused by 15 min-
utes of ventricular fibrillation (VF), followed by conventional CPR with ad-
vanced life support (CPR–ALS). In the treatment group (n ¼ 7) circulatory
arrest was caused by 15 minutes of VF, followed by reperfusion of the
whole body with cardiopulmonary bypass (CPB).
Control Group
Animals (55.3 5.7 kg body weight [BW]) were premedicated with 0.5
mg/kg BW midazolam and 20 mg/kg BW ketamine intramuscularly and
anesthetized with propofol (1%). Endotracheal intubation followed intrave-
nous pancuronium (0.2 mg/kg BW), and 12 to 15 breaths/min were provided
by a volume-controlled ventilator (Servo 900C; Siemens Elema, Solna,
Sweden) at 10 to 15 mL/kg BW tidal volume and 5 mm Hg positive end-ex-
piratory pressure, with setting adjustment to normalize oxygen and carbon
dioxide tension and pH values. Anesthesia and muscle paralysis was main-
tained with fentanyl (2 mg $ kg1 BW $ h1), isoflurane (1.5% to 2.0%) and
pancuronium (0.2 mg $ kg1 BW $ h1). Fluid requirements were substituted
with Ringer solution (10 mg $ kg1 BW $ h1). Electrocardiographic results,
body temperature, and oxygen saturation were monitored continuously.
All procedures were performed in a sterile setting; 30 mg/kg BW cefo-
tiam was administered for infection prophylaxis. Two incisions were
made for vascular access (right neck) and induced VF (epigastric region).
Systemic blood pressure was monitored from the right carotid artery. A
pulmonary artery catheter (Arrow International, Reading, Pa) was inserted
through the right subclavian vein. Cardiac output was measured with a ther-
modilution technique. A bipolar catheter was approached through the epi-
gastric incision for inducing VF. Before VF induction, heparin (300 IU/
kg BW) and pancuronium (0.2 mg/kg BW) were administered systemically.
A muscle relaxant was administered to reduce leg movement during defi-
brillation.
VF was then induced, the respirator was disconnected, and normother-
mic CA was maintained for 15 minutes. CPR–ALS (according to American
Heart Association/American College of Cardiology standards, including
manual chest compression, bag ventilation through an endotracheal tube,
defibrillation, and inotropic and antiarrhythmic drug application) was
started for at least 20 minutes and continued until the animal regained stable
hemodynamics. If circulation could not be re-established during the 20-min-
ute CPR–ALS period, the experiment was terminated, and the dead animal’s
brain was removed immediately and stored in formalin solution for histo-
logic examination.1326 The Journal of Thoracic and Cardiovascular SurTreatment Group
In addition to the aforementioned procedure, animals in the treatment
group (57.0 8.5 kg BW) required a third incision (right groin) for femoral
artery access.
Heparin was administered systemically (300 IU/kg BW), a 14F cannula
was placed in the right femoral artery, and a 24F cannula was inserted in the
right external jugular vein (all cannulas: MEDOS Medizintechnik AG,
Stolberg, Germany) before the ischemic period.
CPB included conventional 3/8-inch tubing, a membrane oxygenator
(Hilite 7000), a venous reservoir (MVC 4030) and a diagonal pump (Delta-
stream DP2; all MEDOS Medizintechnik AG) connected to a heat exchanger
(Sto¨ckert, Sorin-Group Deutschland, Munich, Germany). We inserted an
LG-6 filter in the arterial line to diminish the leukocyte-mediated endothelial
injury (Pall Medical, East Hills, NY) and a probe for continuous online blood
gas monitoring (CDI 500; Terumo, Ann Arbor, Mich). Priming consisted of
700 mL of Ringer solution and 15,000 IU of heparin. We added 300 mL of
citrate-phosphate-dextrose (to bind calcium and prevent intracellular cal-
cium accumulation followed by intracellular edema) and 2 g of magnesium
sulfate (to reduce intracellular calcium by inhibiting calcium entry across cel-
lular membranes and to displace calcium from binding sites on the sarcolem-
mal membrane). Mannitol 20% (2 g/kg BW; acting as a free radical
scavenger and to limit intracellular edema) and 10 mg/kg BW lidocaine
(to stabilize the heart rhythm) were added to the priming solution (Table 1).
CPB was initiated for 60 minutes after the 15 minutes of CA. Systemic
blood pressure was maintained at 30 to 40 mm Hg for the first 3 to 5 minutes
to provide gentle initial reperfusion (Table 2) and increased thereafter to 50
to 60 mm Hg with full-flow CPB (70–80 mL $ kg1 $ min1). For faster ce-
rebral cooling and prolongation of reduced cell metabolism, a pH regimen
on CPB was set for pH-stat for the first 30 minutes and changed to alpha-stat
during rewarming.
Body temperature was decreased to 30C (in reference to the recommen-
dation of the International Liaison Committee on Resuscitation) through the
CPB arterial reflow with a maximum gradient of 10C versus the venous
return. Rewarming occurred after 30 minutes to a minimum of 34C after
60 minutes of CPB (Table 2) with attention to the species-specific suscep-
tibility of malignant hyperthermia.
External defibrillation was performed after starting CPB (Marquette
Hellige CardioServ, Freiburg, Germany) and repeated until a regular heart
rhythm was established.
Blood gases and activated clotting times were measured every 15 to 30
minutes (Blood Gas Analyzer, Roche Cobas b 121; Roche Diagnostics
GmbH, Mannheim, Germany). CPB was stopped after 60 minutes, followed
by cannula removal. The vessels were repaired, all wounds were closed, and
protaminhydrochlorid (200 IU/kg BW) applied. Animals were allowed to
regain consciousness, extubated, and transferred to the stable for further
monitoring and care.Postoperative Care
Animals were monitored for 24 hours (protocol 1) or 7 days (protocol 2)
after CPB. Euthanasia was performed with 30 mg/kg pentobarbital and sub-
sequent potassium chloride after 24 hours or after a magnetic resonance im-
aging (MRI) scan of the brain on day 7. The brain was removed immediately
after death and stored in formalin solution for histologic examination.Parameters
Neurological scoring. Neurological status was assessed before an-
esthesia and every 24 hours after CPB by using a species-specific behavior
scale (Neurological Deficit Score [NDS]). Appendix E1 shows the 5 general
neurological examination components, with a maximum score of 100 in
each category: 0 is normal, and 500 indicates brain death.
Video documentation. Key sequences of the experiments per-
formed under the amended protocol were recorded on videotape.gery c May 2010
TABLE 1. Priming of CPB (700mL) and composition of the controlled
reperfusate
Control cardiac rhythm Lidocaine, 10 mg/kg BW
Deplete leukocytes LG-6 filter in arterial line for the first 10 min
Hypocalcemia CPD, 300 mL (Caþþ 0.2–0.5 mmol/L)
Magnesium Mgþþ, 2 g
Mannitol 2 g/kg BW
CPB, Cardiopulmonary bypass; BW, body weight; LG-6, leukocyte reduction arterial
blood filter (LeukoGuard-6l Pall Medical, East Hills, NY); CPD, citrate-phosphate-
dextrose.
Trummer et al Perioperative ManagementMRI. MRI examination was performed before inducing CA (baseline), at
the end of the experiment after 7 days, or, if indicated, at any time before.
Animals were premedicated as described above and mechanically venti-
lated. The imaging protocol included these sequences: (1) axial T2-
weighted turbo spin echocardiographic sequence with an in-plane resolution
of 0.43 0.4 mm2, 4-mm slice thickness, and a total number of 23 slices and
(2) axial echocardiographic planar diffusion–weighted sequence at b ¼
0 and b ¼ 1000 s/mm2, with an in-plane resolution of 1.3 3 1.3 mm2 in
otherwise geometric parameters identical to the T2-weighted series.
Contrast-to-noise ratios of the T2-weighted series and maps of the appar-
ent diffusion coefficient (ADC) from the selected brain regions (frontal lobe,
occipital lobe, basal ganglia, hippocampus, and cerebellum) of the final
MRI were compared with those of baseline images.
Histologic examinations. Brain histology from healthy pigs was
performed in 3 separate animals to investigate potential damage from the
procurement procedure.
Formalin-fixed brain tissues from the frontal lobe, thalamus, striatum,
hippocampus, posterior brain stem, and cerebellar hemispheres were em-
bedded in paraffin. Four to 5-mm-thick sections were stained with hematox-
ylin and eosin; neuronal apoptosis was detected with terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling staining.
Hemodynamic data. Hemodynamic measurements were taken be-
fore inducing VF (baseline) and after discontinuing CPB. Cardiac output
was measured by using a thermodilution technique with derived hemody-
namic parameters (cardiac index, systemic vascular resistance index, and
pulmonary vascular resistance index). Number of shocks, time to regain sta-
ble heart rhythm, and total CPB time were recorded.
Temperature measurements. For continuous temperature mea-
surement, a probe was placed in the nasopharyngeal region and in the
CPB circuit lines.
Biochemical data. Arterial blood was sampled at baseline and the
end of CPB. Further samples were taken at the end of the experiment.
Creatinine kinase and serum transaminases. Cellular in-
jury was determined by measuring creatinine kinase, serum aspartate ami-
notransferase (AST), and alanine aminotransferase (ALT) activity by
using the UV-spectrophotometric method (Sigma Chemical Co, St. Louis,
Mo) and expressed as units per milliliter of plasma.
Neuron-specific enolase. Neuron-specific enolase as a marker for
brain injury was quantified with an Enzyme Immunometric Assay (SynX
Pharma, Inc, Toronto, Ontario, Canada).TABLE 2. Protocol of the conditions of reperfusion
Controlled reperfusion pressure 30-40 mm Hg for the first 3-5 min
after circulatory arrest
Controlled reperfusion flow 70-80 mL $ kg1 BW $ min1
Controlled blood temperature Cooling to 30C for the first 30 min,
warming thereafter to 34C
Controlled blood pH pH-stat during cooling, alpha-stat
during rewarming
BW, Body weight.
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MStatistical Analysis
To statistically evaluate the region-of-interest analysis of magnetic
resonance data, we used SPSS 15.0 software (SPSS, Inc, Chicago, Ill). After
proved normality, a 2-sided Student’s t test for equal variances and a Welsh
test for unequal variances were applied. A Bonferroni correction was
performed, and data were expressed as means  standard deviations.
RESULTS
Mortality
Control group. All animals died after a period of 20 min-
utes of CPR–ALS. VF was not terminated, nor was stable
circulation re-established.
Treatment group. All animals survived and were trans-
ferred to the stable 2.6  0.3 hours after the end of surgical
intervention.
Neurological Deficit Score
Control group. No neurological recovery was recorded be-
cause of the 100% mortality described above.
Treatment group. The NDS was 98  31 in all animals
(n ¼ 7) at the 24-hour time point (see Figure 1). The NDS
decreased further to 0 after 48 hours in 4 of 5 animals that
were eligible for the 7-day observation period (according
to the amendment) and remained at 0. Temporary seizures
occurred during the early postoperative period (<48 hours)
in 5 animals, which were treated with intravenous applica-
tion of calcium and, if necessary, benzodiazepines. One
animal regained full consciousness and accepted food and
water but was unable to stand up and walk within 3 days
after surgical intervention (NDS ¼ 110). It was killed on
day 3.
VF Induction and Electrocardiographic Changes
During 15 Minutes of Ischemia
VF induction was established quickly in all experiments
(n ¼ 11). Initial electrocardiographic results showed high-
frequency VF followed by torsade de pointes, which dimin-
ished within 3 to 5 minutes to low-amplitude VF close to the
zero line. No animal regained a regular rhythm spontaneously.
VF Termination
Control group. One hundred percent mortality (n ¼ 4) oc-
curred because VF could not be terminated despite recurrent
defibrillation and intravenous antiarrhythmic medication.
Treatment group. External defibrillation (9  5 shocks)
with increasing energy up to 360 Joules was necessary in
all animals (n ¼ 7) during the first minutes of reperfusion.
A regular heart rhythm was established within 4.8  1.8
minutes after initiating CPB and maintained during and after
CPB (see Table E1).
Hemodynamic Data
Control group. Mean arterial pressure (MAP) was main-
tained at 32.7  10.6 mm Hg during CPR–ALS. Flow was
not measured in this group.diovascular Surgery c Volume 139, Number 5 1327
FIGURE 1. Neurological Deficit Score (NDS): treatment group. The experimental group included 7 animals. The NDS was 98  31 after 24 hours. Two
animals had to be killed after 24 hours during the limited observation time of the initial protocol. The extended observation period was applicable for 5 an-
imals. The NDS decreased to 0 after 48 hours in 4 of these 5 animals. One animal regained full consciousness and accepted food and water but was unable to
get up and walk within the first 3 days after the operation (expressed as an NDS of 110 at that time).
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MTreatment group. As shown in one experiment in
Figure E2, MAP decreased within 30 seconds after VF induc-
tion to 15 4 mm Hg. MAP increased within the following 3
to 5 minutes to a maximum of 19  5 mm Hg, followed by
a final decrease to 8 6 mm Hg. Pulmonary artery pressures
decreased to values corresponding to central venous pressure.
MAP after the start of CPB was kept at 35  7 mm Hg
(2 minutes) and 46  16 mm Hg after 5 minutes, with
corresponding flow rates of a CPB of 44  10 mL $ kg1 $
min1 (2 minutes) and 46  12 mL $ kg1 $ min1 (5 min).
Low–dose norepinephrine was used in all experiments to
maintain an arterial pressure between 50 and 60 mm Hg
with a CPB flow of 67  13 mL $ kg1 $ min1.Nasopharyngeal Temperature
Control group. The animals’ temperature decreased from
37.3C  0.5C to 35.9C  0.3C after 15 minutes of
VF. The temperature at the end of the experiment after 20
minutes of CPR–ALS was 35.1C  0.4C.
Treatment group. Temperature decreased from 37.1C 
0.3C to 36.1C  0.4C after 15 minutes of VF. After the
start of CPB, the animals were immediately cooled down.
Six animals (n ¼ 6) attained a nasopharyngeal temperature
of 29.6C  2.1C after 30 minutes of CPB. Because of
heat-exchanger failure, 1 animal was cooled to 25.0C after
30 minutes with an uneventful consecutive course. All ani-
mals (n ¼ 7) in the experimental group were rewarmed on
CPB, achieving a temperature of 35.0C  0.9C at the
time of separation from CPB.pH Values
Control group. After 15 minutes of CA, the earliest blood
draw was possible after 3 to 5 minutes of manual chest com-1328 The Journal of Thoracic and Cardiovascular Surpression. Metabolic alkalosis (pH 7.57  0.18) was present
at this time.
Treatment group. Drawing blood from the arterial line in
the right carotid artery was not possible after 15 minutes
of CA. We therefore obtained the blood gases from the arte-
rial line of the CPB 1 to 2 minutes after the start of CPB.
Starting from normal values at baseline (pH 7.48  0.40),
blood gas analysis indicated a metabolic acidosis (pH 7.19
 0.10) in all animals after 15 minutes of VF. pH values
remained low by using the pH-stat strategy during the first
30 minutes of CPB and returned to pH 7.36  0.05 with
the alpha-stat strategy during rewarming on CPB.Separation From CPB and Respirator Weaning
Control group. No control pigs developed circulation, and
all animals died after a period of 20 minutes of CPR–ALS.
Treatment group. All animals were weaned off CPB after
64 5 minutes (see Table E1). In 4 animals low-dosage ino-
tropic support (0.06 mg $ kg1 BW $ min1 epinephrine or 10
mg $ kg1 BW $ min1 dopamine) was necessary at the time
of weaning from CPB. The other animals (n ¼ 4) were sep-
arated from CPB without inotropic support. No animal re-
quired inotropic or vasoactive agents 2 hours after CPB.
The animals were weaned from the respirator 140.0  8.7
minutes after CPB. Heart rate and cardiac index were in-
creasing more at the end of the operation than at baseline
without increased filling pressures (see Table E2).Renal Function
Diuresis was sufficient in all 7 animals in the treatment
group. Blood gas analysis at the end of the experiment re-
vealed baseline values for hematocrit, potassium, and pH.gery c May 2010
FIGURE 2. Magnetic resonance imaging (MRI) and brain histology. A, MRI was performed with a focus on apparent diffusion coefficient (ADC) and T2-
weighted (T2W) brain images. White circles are placed within the region of interest. Coronary slices of the frontal lobe (panel A, ADC; panel B, T2 weighted)
represent the animals’ status 7 days after normothermic ischemia. Note that ADC is lower 7 days after normothermic ischemia as a substrate of intracellular
edema after acute ischemia of the brain (panel C, ADC), whereas T2-weighted slices do not show a change in signal intensity compared to control (panel D,
T2). B, Histology of the brain of a healthy animal without ischemia (left: panels A and C) compared with that of an animal after 15 minutes of cardiac arrest
with complete functional recovery (right: panels B, D, and E). Hematoxylin and eosin stains showing hypoxic neurons, astrocytosis, and blood vessel and
macrophage activation (panel B, arrows), which are absent in the control animal. Neuronal apoptosis is absent in the control animal (panel C) and confirmed in
the hypoxic animals (panels D and E, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining).
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Control group. Biochemical data showed values close to
baseline at the end of the experiment after 20 minutes of
CPR–ALS (see Table E3).
Treatment group. Animals (see Table E4) showed slightly
increased AST (49  33 U/L) and ALT (93  77 U/L)
values at the end of the experiment compared with baseline
values (AST, 34  8 U/L; ALT, 37  17 U/L). After intra-
muscular injection, creatinine kinase levels were increased
at baseline (2171  859 U/L), increasing after CPB (3225
 2587 U/L) and decreasing at the end of the experiment
(2739  2272 U/L). Neuron-specific enolase levels re-
mained at baseline values (0.20  0.10 mg/L) at the end of
CPB (0.20  0.08 mg/L), with higher values at the end of
the experiment after 7 days (1.00  0.30 mg/L).The Journal of Thoracic and CarBlood gas analysis showed a rapid decrease in ionized cal-
cium levels from 1.39  0.03 mmol/L (baseline) to 0.58 
0.28 mmol/L at the 10-minute time point after the start of
CPB but returned to 1.14  0.13 mmol/L at the end of sur-
gical intervention.
MRI
In the treatment group MRI examination was performed at
baseline (n ¼ 5) and at the end of the experiment on day 7
(n ¼ 4). The MRI of one animal took place after 72 hours.
The ADC of the frontal gray matter differed significantly
from that at baseline (52.3  17.1 vs 17.6  17.0, P ¼ .01).
No significant differences were apparent in any of the other
region of interest measurements from the ADC maps and
T2-weighted images. An ADC map and T2-weighteddiovascular Surgery c Volume 139, Number 5 1329
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Mimages of the brain before and after treatment are presented
(Figure 2, A).
Brain Histology
In the treatment group generalized hypoxic damage was
moderate. Individual hypoxic neurons and diffusely spread
neurons underwent apoptosis. Morphologic signs of hyp-
oxic brain damage were mainly confined to the hypoxia-sen-
sitive CA4, CA3, and CA1 hippocampal areas, whereas
CA2 and the other brain regions revealed minor changes
(Figure 2, B).
DISCUSSION
Despite continuous efforts in the medical community, the
chances for survival after sudden CA remain poor, and if sur-
vived, it is often accompanied by persistent cerebral fail-
ure.1,14 Myocardial stunning and brain reperfusion injury
follow when spontaneous circulation is restored through
CPR.2,15 The duration of CA before CPR is the most impor-
tant outcome determinant; survival is up to 50% after early
defibrillation and CPR within 4 to 5 minutes, but when that
interval is doubled, survival is negligible.2 It is generally be-
lieved that irreversible brain injury occurs after 5 minutes of
no-flow, normothermic whole-body ischemia (CA), and neu-
rological injury increases proportionally to longer CA dura-
tion.16 Consequently, delaying CPR after prolonged CA
periods (>10–15 minutes) results in greater than 95% mor-
tality and usually irreversible brain damage in survivors.5
Slightly better overall outcomes follow when emergency
CPB is initiated to restore cardiocerebral resuscitation after
effective CPR–ALS to treat CA, but neurological mortality
remains high.17 Eighty percent to 100% survival is experi-
mentally possible when normothermic CPB is introduced
5 to 10 minutes after CA in dogs,16 but mortality increases
to approximately 80%, and no neurological recovery is pos-
sible when CPR–ALS is started after 12.5 minutes of exper-
imental CA.18 Yet using CPB for mechanical circulatory
support after 12.5 minutes of CA increased survival to
70%, and 50% of those dogs regained consciousness after
72 hours.19 However, when extending the CA duration to
15 minutes, there is no survival with CPR–ALS, and al-
though CPB increases survival to approximately 25% to
80%, it does not compensate for severely impaired neuro-
logical recovery.16
In sharp contrast to those studies, we did not use CPR and
succeeded in demonstrating clinically apparent neurological
and myocardial recovery after 15 minutes of normothermic
CA in pigs treated by controlling the conditions and compo-
sition of the reperfusate. This study design differs from prior
body ischemic insult (CA) studies in which CPR–ALS or
CPB resuscitation protocols used normal blood as the primary
reperfusate. The tenet of our approach is that immediate nor-
mal blood cerebral reperfusion is responsible for the fate of ce-
rebral tissue because neurons are known to function for up to1330 The Journal of Thoracic and Cardiovascular Sur60 minutes during ischemia alone,20 an implication consistent
with prior statements that the maximum ischemic tolerance of
myocardial and skeletal muscle cells is unknown.9,21
Lethal ischemia–reperfusion injury can occur in already
injured cerebral tissue and cardiac muscle cells when normal
blood is the primary reperfusate because the latter can acti-
vate potential mediators that include oxygen and calcium
paradox, pH paradox, inflammation, calcium overload, and
water accumulation within the cell.9,22 Cerebral dysfunction
can be exacerbated secondarily by cerebral perfusion reper-
fusion injury that triggers delayed neuronal cell death during
the first 3 reflow days.15
Deep hypothermic circulatory arrest is an important tool
for neuroprotection during aortic surgery and allows a safe
period of circulatory arrest of 25 minutes at 18C. The im-
plementation of strategies to control the conditions of reper-
fusion and the reperfusate after deep hypothermic
circulatory arrest allows prolonged periods of CA up to 90
minutes with clinically apparent neurological recovery.23
Therefore our new concept is designed to counteract the me-
diators of reperfusion injury by controlling the conditions of
reperfusion and the composition of the initial reperfusion
phase (Tables 1 and 2) during an initially controlled reperfu-
sion phase as primary treatment before normal blood from
the whole body enters the ischemically injured cells. This
global approach is based on our previous studies of ische-
mia–reperfusion injury and their treatment in isolated or-
gans, such as the myocardium,8,9,22 skeletal muscle,13
lung,11 and kidney,12 as well as in the whole body during hy-
pothermic CA.24 Unlike this concept, conventional CPR–
ALS involves uncontrolled reperfusion of the whole body
with only normal blood perfusion and a cerebral perfusion
pressure seldom exceeding 40 mm Hg, providing only
10% to 15% of normal cerebral blood flow, an intervention
that might do more damage than no flow at all.
Our data show survival of all (n ¼ 7) animals in the treat-
ment group, with clinically apparent neurological recovery
in 6 of 7. Follow-up was possible in 5 animals for 7 days,
and neurological recovery persisted during that period.
Myocardial recovery occurred quickly: few defibrillations
were required on CPB to terminate VF and establish stable
cardiac rhythm, followed by a short time on CBP. Early ex-
tubation and unimpaired hemodynamic data highlight the
treatment group’s impressive cardiac performance, which
stands in sharp contrast to that of the control group, in which
all animals undergoing CPR–ALS died from continuous VF
or the inability to establish stable circulation.
Despite clinically apparent neurological recovery, MRI
examination of the brain revealed intracellular edema in
the frontal gray matter after 7 days. We observed no signif-
icant differences in any of the other ADC maps and T2-
weighted images. Brain histology after 7 days revealed
that most brain regions had mild histologic changes, mainly
in the hypoxia-sensitive hippocampal areas CA4, CA3, andgery c May 2010
Trummer et al Perioperative ManagementCA1, which showed signs of apoptosis. We conclude that
a certain amount of brain damage still occurs, although to
a limited extent, permitting recovery and survival. We
plan to investigate this issue, which was not examined in
this study, in our future research.
Study limitations include the use of juvenile animals and
their potentially better neurological recovery. Beyond that,
systemic heparinization for CPB was applied before CA
induction, but our dosages were much lower (300 IU/kg)
than the large dose (700 IU/kg)25 that improved survival
and neurological recovery whereby only 2 dogs were normal
and 4 of 6 were arousable. Furthermore, volatile anesthetics
can limit ischemic cerebral injury.26 Our model would be
more readily comparable with routine patients with CA if
the same experiments were conducted in lightly sedated an-
imals without administering heparin, muscle relaxants, iso-
flurane, and mechanical ventilation. However, we did not
get approval from the regulatory authorities for animal re-
search to use lightly sedated animals.
In conclusion, we present data showing 100% survival of
pigs after 15 minutes of normothermic CA and clinically ap-
parent neurological recovery in 6 of 7. This is in contrast to
current treatment methods, with which resuscitation is only
successful after CA times of 3 to 5 minutes, followed by fre-
quent neurological damage in the few survivors. This far bet-
ter survival and neurological outcome after prolonged
cardiac standstill is possible by treating the tissues damaged
previously by ischemia (CA) before normal blood reperfu-
sion is reinstituted. This new treatment consists of a modified
reperfusate and controlled conditions of reperfusion for the
initial 60 minutes using peripheral extracorporeal circula-
tion. We thus provide evidence that challenges the usual
100% mortality after 15 minutes of normothermic CA. If
our experimental results are confirmed by others in future
studies, resuscitation with CPB might evolve as a powerful
new tool in patients with sudden CA.P
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Dr Ani Anyanwu (New York, NY). I have nothing to disclose.
This study is unique, and its authors are to be commended be-
cause they demonstrated survival with relatively preserved neuro-
logical recovery after 15 minutes of normothermic CA. Your
study differs from prior studies of resuscitative CPB by applying
controlled reperfusion, the theory being that subjecting the ische-
mic body cells to normotensive normal blood reperfusion as in con-
ventional CPB might be deleterious and result in secondary injury.
There are, however, several components to your intervention
that could explain the results.
This leads to the first of my 3 questions. You necessarily hepa-
rinized your animals before CA, presumably to allow cannulation
of vessels in preparation for later perfusion. To what degree dodiovascular Surgery c Volume 139, Number 5 1331
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Myou think heparinization could have contributed to your results?
Did you consider an alternative study design in which the animals
were heparinized and swiftly cannulated after CA?
Dr Trummer. Thank you very much for those very good
questions.
We expected this problem in our study, and we heparinized only
300 U/kg BW. The control group was heparinized at the same time,
and the animals in the control group died. Therefore we do not
really see a big effect on the heparin.
On the other hand, with the knowledge we have from those ex-
periments right now, we also would assume it is possible to place
the catheters without administering heparin, but then you might
have the risk of losing more animals in the treatment group because
of clotting. However, it should be possible just to start the pump
only with heparin and not administer heparin before.
Dr Anyanwu. Obviously in a clinical situation you could not
heparinize before arrest.
This takes me to the issue of the control group, which you men-
tioned. Your control group consisted of animals undergoing con-
ventional CPR after prolonged normothermic arrest, a condition
that we know from previous studies is not survivable. This was ex-
pectedly demonstrated in your results. I would argue therefore that
your control group was wasted and somewhat irrelevant. The pre-
ferred control group would have been animals undergoing conven-
tional hypothermic CPB after prolonged arrest. In that way we
could separate the effect of the controlled reperfusion from that
of CPB. This leads to my second question: What was the basis
for your choice of control group for this experiment?
Dr Trummer. Thank you very much for this comment. We per-
formed many pilot studies before this study. In those pilot studies
we performed CPR after 15 minutes of arrest and then started the
animals on bypass. Primarily in this group, 35% of the animals
died, and the subsequent 65%, or two thirds of them, had to
undergo bypass because they deteriorated with circulation.
We thought that would not be the right group to compare
because we hypothesized that conventional CPR reflects an uncon-
trolled reperfusion. Therefore, we chose animals with conventional
CPR as control group.
Dr Anyanwu. It then becomes difficult to isolate the effects of
controlled reperfusion.
Finally, being a clinician, I am interested in how I can extrapo-
late these findings to my clinical practice. It is impractical to expect
that we can use CPB to resuscitate all patients undergoing cardiopul-
monary arrest. Nevertheless, assuming you repeated these experi-
ments with conventional bypass controls and showed the same
results, there would be 2 things that I would choose to take back to
my practice from your study. First, when patients have CA intraoper-
atively or in the intensive care unit requiring emergency CPB, then
perfusion, once established, should first use a specified reperfusate
and be maintained at a low pressure for the first few minutes. Second
is that when I subject the heart or brain to ischemia, as in cardioplegic
arrest, heart transplantation, or cerebral circulatory arrest, I should al-
ways use some form of controlled reperfusion to re-establish perfu-
sion. Do you think these are valid extrapolations? Have you
changed your own practice in any way as a result of your study?
Dr Trummer. Thank you very much for this comment. That is
a thing of the future, and that is completely correct. Before we can
go out to the field, we have to do it within the hospital, within the1332 The Journal of Thoracic and Cardiovascular Suroperating room or the intensive care unit; that is where we have to
start it if we want to establish this new method of reperfusion. We
cannot go out and eradicate CPR in the field; that is not possible
right now, but it is one of the visions we have.
DrAnyanwu. I am asking the following: if I have a patient in the
operating room who has a CA, should I use a similar technique to
resuscitate them today?
Dr Trummer. From the results we have right now, it should be
possible to do it. We just did it now in animals but have not done it
in patients yet. Once we have more results, then we would go to the
ethical committee to prove that within clinical practice.
DrRichardJ. Shemin (LosAngeles,Calif). I have no disclosures.
This was a very interesting study, but the details of CPB are key to
understanding exactly what is going on here. Obviously, these pigs
look big, but I am sure they are juvenile pigs, and therefore the first
question is this: Do you think that there is some aspect between the
maturity of the animal and the potential recovery with this technique?
Dr Trummer. Thank you very much for this comment. That is
a potential limitation we discussed because these are juvenile pigs,
and those are around 50 to 60 kg. However, that is a moveable size
because the pigs have to stand up later on; if they are too big, they
cannot stand up anymore. That is one thing how to conduct the ex-
periment.
On the other hand, we needed a lot of things in the pump to get to
this point, a low perfusion pressure and low flow. We implemented
leukocyte filters; we were running them on pH stat, cooling them
down. Therefore there were a lot of things that I was unable to pres-
ent right now because we would go over the time.
Dr Shemin. So low pressure and low flow?
Dr Trummer. Low pressure, low flow, leukocyte filters in there,
cooling down and leaving the animals in pH stat immediately to
leave the cell in an acidotic environment to stop the metabolism
in there. That was the goal we wanted to achieve.
Dr Shemin. So what temperatures did you cool to?
Dr Trummer. We cooled them down immediately to 30C,
which we reached about 10 minutes after we started the pump.
Dr Shemin. One of the key aspects in your control group is that
all the animals failed to achieve hemodynamic stability and died,
and therefore you do not know anything about neurological recov-
ery in that group.
Dr Trummer. However, as I mentioned before, we did some ex-
periments at the University of California, Los Angeles, in which we
saw that the animals really came out poorly after conventional
CPR, irrespective of whether we started them later on bypass. If
the animals do not get out of VF, mortality is 100%.
Dr Shemin. The other aspect, and my final question, regards the
effect of the anesthetic. Obviously both groups received it, but ob-
viously to induce fibrillation during anesthesia actually probably
has some protective effect also.
Dr Trummer. That is completely correct. And we also tried to
get to this point, but right now it is not possible to conduct this ex-
periment on an awake animal. We took electroencephalograms
from the animals in previous studies and tried to keep the animal
as awake as possible looking to the electroencephalograms. There-
fore we save on anesthesia to avoid the protective effects, but that is
the only thing we can do right now.
Dr Shemin. What anesthetic agent did you use?
Dr Trummer. Isoflurane, low dose, and propofol.gery c May 2010
Appendix E1. Neurological Deficit Score
A. Central nerve function (0–100 points): pupil size (0–10);
eye position (0–10); light, lid, and corneal reflex (each
0–10); ciliospinal and oculocephalic reflex (each
0–10); auditory and gag reflex (each 0–10); carinal reflex
(0–10)
B. Respiration (0–100 points): normal (0), hyperventilation
(25), abnormal (50), absent (100)
C. Motor sensory function (0–100 points): stretch reflex
(0–25), motor response to pain (0–25), positioning
(0–25), muscle tonus (0–25)
E. Level of consciousness (0–100 points): normal (0),
cloudy (30), delirium (45), stupor (60), coma (100)
F. Behavior (0–100 points): drinking, chewing, sitting, and
standing (each 0–15); walking (0–40)
The total score is the sum of all sections (0, normal; 500,























































FIGURE E1. Mean arterial pressure before, during, and after 15 minutes of ventricular fibrillation (VF) in a single experiment. The figure shows an unmod-
ified mean arterial pressure curve, including all artifacts caused by blood draw or defibrillations (arrows). Note the spontaneous increase in arterial pressure
caused by peripheral vasoconstriction after ventricular fibrillation initiation followed by arterial pressure of less than 10 mm Hg after 5 minutes of ventricular
fibrillation. As part of the controlled reperfusion strategy, arterial pressure is kept low for the first 3 to 5 minutes on cardiopulmonary bypass (CPB). The animal
is taken off CPB after 60 minutes of controlled whole-body reperfusion.
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TABLE E1. Perioperative data after 15 minutes of cardiac arrest
(n ¼ 7)
Defibrillations to terminate VF (n) 9  5
Time needed to stable SR (min) 4.8  1.8
CPB (min) 63.8  5.1
Extubation after CPB (min) 140.0  8.7
Discharge to stable (h) 2.6  0.3
VF, Ventricular fibrillation; SR, sinus rhythm; CPB, cardiopulmonary bypass.
TABLE E2. Hemodynamic data before CPB, after CPB, and at the






HR (beats/min) 78  16 96  34 114  12
MAP (mm Hg) 80  7 67  14 61  10
AP, systolic (mm Hg) 103  6 89  23 100  4
AP, diastolic (mm Hg) 63  9 53  6 40  11
MPAP (mm Hg) 12  3 25  2 18  2
PAP, systolic (mm Hg) 19  2 34  4 30  2
PAP diastolic (mm Hg) 6  4 17  6 9  6
CVP (mm Hg) 4  2 6  3 8  4
PCWP (mm Hg) 5  3 4  2 9  4
CI (L $ min1 $ m2) 4.6  1.1 5.1  0.6 5.2  1.1
SVI (mL $ beat1 $ m2) 61  13 55  17 46  11
SVRI (dynes $ s1 $ cm5 $ m2) 1382  33 1166  14 827  33
PVRI (dynes $ s1 $ cm5 $ m2) 120  4 404  8 140  5
LVSWI (g $ m1 $ m2) 66  16 54  18 38  10
RVSWI (g $ m1 $ m2) 9  3 18  8 11  3
CPB, Cardiopulmonary bypass; HR, heart rate; MAP, mean arterial pressure; AP, ar-
terial pressure; MPAP, mean pulmonary arterial pressure; PAP, pulmonary arterial
pressure; CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure;
CI, cardiac index; SVI, stroke volume index; SVRI, systemic vascular resistance index;
PVRI, pulmonary vascular resistance index; LVSWI, left ventricular stroke work index;
RVSWI, right ventricular stroke work index.
TABLE E3. Biochemical data: Control group (n ¼ 4)
Baseline End of experiment
AST (U/L) 28  9 37  18
ALT (U/L) 59  7 48  6
CK (U/L) 4937  3547 4243  2893
NSE (mg/L) 0.5  0.1 0.5  0.0
AST, Aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatinine
kinase; NSE, neuron-specific enolase.
TABLE E4. Biochemical data: Treatment group (n ¼ 4)
Baseline End of CPB
End of experiment
(day 7)
AST (U/L) 34  8 36  15 49  33
ALT (U/L) 37  17 31  7 93  77
CK (U/L) 2172  859 3225  2587 2739  2272
NSE (mg/L) 0.20  0.10 0.20  0.08 1.00  0.30
AST, Aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatinine
kinase; NSE, neuron-specific enolase.
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